Couldn't find anything.
There is a new trial of Byetta (another Diabetes drug) that is taking place in England. But I don't know if it stimulates this particular protein.
The link you provided says that MJFF provided some funding for the study. I don't get why four years have gone by without a trial.
Cal
Quote:
Originally Posted by Conductor71
Yep, that's why I wondered whether this was just old but updated news which essentially it is. Researchers were onto this four years go, but I guess the genetic link and the master switch thing are the key new developments.
The brand name is Actos. I guess this is one of the few that doesn't have nasty cardiac side effects. There is a really great article in Nature on all of this. You'll love this quote:
... a clinical trial to test Actos in patients with Parkinson's disease has already been approved by regulators.
Nature article
No trial to date that I can find at clinicaltrials.gov
Laura |